PMO Interview with the Innovator Series: Volume 7

Video Categories: PMO Interview with the Innovator Series

Listen as some of the top academic and community thought leaders in multiple myeloma define what precision medicine means to them.
October 8, 2014

Risks with Cytoreductive Therapy

Hear Dr. Michaelis discuss cytoreductive therapy and the risk factor for patients with hemorrhage.Supported through funding from Incyte

December 3, 2013

Management of Patients with Basal Cell Carcinoma not Eligible for Surgery or Radiation

In this second clinical commentary entitled, Management of Patients with Basal Cell Carcinoma not Eligible for Surgery or Radiation, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss the need for new treatment options in the care of basal cell carcinoma [ Read More ]